CN105602856B - 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 - Google Patents
黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 Download PDFInfo
- Publication number
- CN105602856B CN105602856B CN201510945197.0A CN201510945197A CN105602856B CN 105602856 B CN105602856 B CN 105602856B CN 201510945197 A CN201510945197 A CN 201510945197A CN 105602856 B CN105602856 B CN 105602856B
- Authority
- CN
- China
- Prior art keywords
- bacterial strain
- aspergillus niger
- culture
- lovastatin
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 59
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 title claims abstract description 55
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 title claims abstract description 55
- 229960004844 lovastatin Drugs 0.000 title claims abstract description 55
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 238000000855 fermentation Methods 0.000 title claims abstract description 51
- 230000004151 fermentation Effects 0.000 title claims abstract description 51
- 241000228245 Aspergillus niger Species 0.000 title abstract description 37
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- 239000001963 growth medium Substances 0.000 claims abstract description 17
- 238000004321 preservation Methods 0.000 claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 22
- 239000002609 medium Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 10
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims description 10
- 239000007836 KH2PO4 Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- 239000008101 lactose Substances 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 5
- 239000012531 culture fluid Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 5
- 238000011218 seed culture Methods 0.000 claims description 5
- 244000113306 Monascus purpureus Species 0.000 claims description 4
- 235000002322 Monascus purpureus Nutrition 0.000 claims description 4
- 235000015278 beef Nutrition 0.000 claims description 4
- 229940057059 monascus purpureus Drugs 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 230000003519 ventilatory effect Effects 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- 239000011686 zinc sulphate Substances 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 13
- 108020004463 18S ribosomal RNA Proteins 0.000 abstract description 8
- 108090000623 proteins and genes Proteins 0.000 abstract description 8
- 230000000877 morphologic effect Effects 0.000 abstract description 7
- 238000012216 screening Methods 0.000 abstract description 7
- 230000002269 spontaneous effect Effects 0.000 abstract description 5
- 244000005700 microbiome Species 0.000 abstract description 2
- 238000012163 sequencing technique Methods 0.000 abstract description 2
- 238000012549 training Methods 0.000 abstract description 2
- 241000228212 Aspergillus Species 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000012010 growth Effects 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 229910052564 epsomite Inorganic materials 0.000 description 4
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000345998 Calamus manan Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 235000012950 rattan cane Nutrition 0.000 description 3
- 241001465318 Aspergillus terreus Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 108091005508 Acid proteases Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000009599 head growth Effects 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002073 mitogenetic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- -1 pectase Proteins 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
- C12R2001/685—Aspergillus niger
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510945197.0A CN105602856B (zh) | 2015-12-16 | 2015-12-16 | 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510945197.0A CN105602856B (zh) | 2015-12-16 | 2015-12-16 | 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105602856A CN105602856A (zh) | 2016-05-25 |
CN105602856B true CN105602856B (zh) | 2019-04-16 |
Family
ID=55983205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510945197.0A Active CN105602856B (zh) | 2015-12-16 | 2015-12-16 | 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105602856B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108004279A (zh) * | 2016-11-01 | 2018-05-08 | 北大方正集团有限公司 | 用于提高洛伐他汀发酵水平的发酵培养基及补料方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0556699A1 (en) * | 1992-02-10 | 1993-08-25 | Novopharm Ltd. | Novel fungal strains and use thereof in antibiotic production |
CN101928701A (zh) * | 2009-06-23 | 2010-12-29 | 华东理工大学 | 提高真菌产酶和次级代谢物的方法 |
CN104561166A (zh) * | 2014-12-01 | 2015-04-29 | 山东中惠食品有限公司 | 一种高产洛伐他汀的生产方法 |
-
2015
- 2015-12-16 CN CN201510945197.0A patent/CN105602856B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0556699A1 (en) * | 1992-02-10 | 1993-08-25 | Novopharm Ltd. | Novel fungal strains and use thereof in antibiotic production |
CN101928701A (zh) * | 2009-06-23 | 2010-12-29 | 华东理工大学 | 提高真菌产酶和次级代谢物的方法 |
CN104561166A (zh) * | 2014-12-01 | 2015-04-29 | 山东中惠食品有限公司 | 一种高产洛伐他汀的生产方法 |
Non-Patent Citations (4)
Title |
---|
EFFECT OF CULTURAL CONDITIONS ON LOVASTATIN PRODUCTION BY ASPERGILLUS NIGER SAR I USING COMBINATION OF RICE BRAN AND BROWN RICE AS SUBSTRATE;Syarifah Abdul Rashid,et al.;《International Journal of Applied Biology and Pharmaceutical Technology》;20130630;第4卷(第2期);摘要 * |
PRODUCTION AND CYTOTOXICITY STUDIES OF LOVASTATIN FROM Aspergillus niger PN2 AN ENDOPHYTIC FUNGI ISOLATED FROM Taxus baccata;Raghunath R,et al.;《International Journal of Applied Biology and Pharmaceutical Technology》;20120930;第3卷(第3期);摘要 * |
Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite production;J.L. Casas López a,et al.;《Enzyme and Microbial Technology》;20030813;第33卷;第270–277页 * |
Raghunath R,et al..PRODUCTION AND CYTOTOXICITY STUDIES OF LOVASTATIN FROM Aspergillus niger PN2 AN ENDOPHYTIC FUNGI ISOLATED FROM Taxus baccata.《International Journal of Applied Biology and Pharmaceutical Technology》.2012,第3卷(第3期),第342-351页. * |
Also Published As
Publication number | Publication date |
---|---|
CN105602856A (zh) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101445784B (zh) | 布雷正青霉变种zjb082702及其发酵制备布雷菲德菌素a的应用 | |
CN106978350A (zh) | 一株黑曲霉及其在普洱茶素类化合物的制备中的应用 | |
CN101085989B (zh) | 一种利用细菌发酵生产番茄红素的方法 | |
CN102010831B (zh) | 一种产洛伐他汀紫色红曲菌霉mpt13 | |
CN1283778C (zh) | N6-(2-羟乙基)腺苷在制备镇痛药物中的应用 | |
CN106047713B (zh) | 一株嗜松篮状菌菌株Li-93及其应用 | |
CN108315265B (zh) | 一种杂色曲霉Av-2菌株及其应用 | |
CN104277985A (zh) | 红曲霉(Monascus purpureus)M-24菌株及其用于Monacolin K制备中应用 | |
CN109468232B (zh) | 一株产阿魏酸酯酶谢瓦散囊菌及其在白酒大曲中的应用 | |
CN105219653A (zh) | 高产洛伐他汀的棒曲霉(Aspergillus clavatus)Ac-32菌株及其应用 | |
CN110551636B (zh) | 一种紫红曲霉my-21菌株及其应用 | |
CN105602856B (zh) | 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 | |
CN106479900B (zh) | 高产洛伐他汀草酸青霉Po-25菌株及其用途 | |
CN110128392A (zh) | 一种由黄曲霉次级代谢产物中分离得到的化合物 | |
CN113337432B (zh) | 一种产吡咯喹啉醌的食甲基菌及其应用 | |
CN106399121B (zh) | 一种紫色红曲菌菌株 | |
CN106754430A (zh) | 高产洛伐他汀枝状枝孢菌Cc‑106菌株及其用途 | |
CN106434366B (zh) | 高产洛伐他汀米曲霉Ao-57菌株和用途 | |
CN101928699B (zh) | 一种提高灵芝漆酶产量的发酵方法 | |
CN109182142B (zh) | 皮落青霉及其应用 | |
CN101008000A (zh) | 一种生产β-胡萝卜素的粘性红圆酵母、β-胡萝卜素及其生产方法 | |
TWI486452B (zh) | 以微生物轉化生產白藜蘆醇(resveratrol)的方法 | |
CN1827633A (zh) | 从蝉拟青霉培养物中提取n6-(2-羟乙基)腺苷的方法 | |
CN104561135B (zh) | 里氏木霉生产芳香物质的方法 | |
CN113337433B (zh) | 一种产吡咯喹啉醌的假单胞菌及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240130 Address after: Room 2920, Building B, No. 9 Hisense Tianchen Road, Jinan City, Shandong Province, 250000 Patentee after: Zhuofan (Jinan) Technology Innovation Co.,Ltd. Country or region after: China Address before: 321004 No. 688 Yingbin Road, Zhejiang, Jinhua Patentee before: ZHEJIANG NORMAL University Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240206 Address after: 710100 Building 6, No. 381 Kunchi 1st Road, Xiliu Street Office, High tech Zone, Xi'an City, Shaanxi Province Patentee after: Shaanxi Didu Pharmaceutical and Chemical Co.,Ltd. Country or region after: China Address before: Room 2920, Building B, No. 9 Hisense Tianchen Road, Jinan City, Shandong Province, 250000 Patentee before: Zhuofan (Jinan) Technology Innovation Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |